
### [NCIT:C39750](http://purl.obolibrary.org/obo/NCIT_C39750)
**Label:** Glioblastoma, IDH-Wildtype

**Subclasses:** [NCIT:C114966](http://purl.obolibrary.org/obo/NCIT_C114966) (Childhood Giant Cell Glioblastoma), [NCIT:C68702](http://purl.obolibrary.org/obo/NCIT_C68702) (Adult Giant Cell Glioblastoma), [NCIT:C9370](http://purl.obolibrary.org/obo/NCIT_C9370) (Adult Brain Stem Gliosarcoma), [NCIT:C68701](http://purl.obolibrary.org/obo/NCIT_C68701) (Adult Gliosarcoma), [NCIT:C3796](http://purl.obolibrary.org/obo/NCIT_C3796) (Gliosarcoma), [NCIT:C4325](http://purl.obolibrary.org/obo/NCIT_C4325) (Giant Cell Glioblastoma), [NCIT:C115365](http://purl.obolibrary.org/obo/NCIT_C115365) (Recurrent Childhood Gliosarcoma), [NCIT:C115363](http://purl.obolibrary.org/obo/NCIT_C115363) (Recurrent Childhood Giant Cell Glioblastoma), [NCIT:C131209](http://purl.obolibrary.org/obo/NCIT_C131209) (Recurrent Gliosarcoma), [NCIT:C114759](http://purl.obolibrary.org/obo/NCIT_C114759) (Childhood Brain Stem Gliosarcoma), [NCIT:C114968](http://purl.obolibrary.org/obo/NCIT_C114968) (Childhood Gliosarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C40558](http://purl.obolibrary.org/obo/NCIT_C40558) (Primary Lesion) 60.00%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 60.00%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 60.00%
- [NCIT:C17757](http://purl.obolibrary.org/obo/NCIT_C17757) (EGFR Gene) 60.00%
- [NCIT:C129264](http://purl.obolibrary.org/obo/NCIT_C129264) (IDH Gene Family Mutation) 60.00%
- Thing 51.45%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 36.30%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 36.12%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 33.83%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 25.83%
- [NCIT:C45581](http://purl.obolibrary.org/obo/NCIT_C45581) (Gene Amplification Abnormality) 21.47%
- [NCIT:C36344](http://purl.obolibrary.org/obo/NCIT_C36344) (Oncogene Deregulation) 21.47%
- [NCIT:C97927](http://purl.obolibrary.org/obo/NCIT_C97927) (Gene Mutant) 18.22%
- [NCIT:C36345](http://purl.obolibrary.org/obo/NCIT_C36345) (Protein Deregulation) 16.62%
- [NCIT:C36336](http://purl.obolibrary.org/obo/NCIT_C36336) (Deregulation of Protein and Messenger RNA Expression) 16.02%


